Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.87
05.11.20
€2.00
05.11.21
-7.97%
06.11.21

Future proof or reliable business model
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€5.90
05.11.20
€20.00
05.11.21
-17.29%
06.11.21

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Delivery Hero SE

Start price
Target price
Perf. (%)
€112.60
05.11.20
€120.00
2.98%
16.12.20

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
EOG Resources Inc.

Start price
Target price
Perf. (%)
€30.40
05.11.20
-
05.11.21
57.24%
09.01.21

High dividend yield expected
Sustainability is little important
Higher risks for its business
Significant cyclical dependencies
buy
Cadence Design Systems

Start price
Target price
Perf. (%)
€103.62
05.11.20
€150.00
05.11.21
48.54%
06.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
ProSiebenSat.1 Media SE

Start price
Target price
Perf. (%)
€9.99
04.11.20
-
27.08%
25.11.20

Risky Investment
buy
Jumia Technologies AG

Start price
Target price
Perf. (%)
€15.20
04.11.20
€49.00
04.11.21
59.87%
19.04.21

Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
buy
Washington Prime Group Inc.

Start price
Target price
Perf. (%)
€4.76
04.11.20
€6.30
04.11.21
-11.41%
06.11.20

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.26
04.11.20
€3.20
04.11.21
-43.45%
10.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Schaeffler AG

Start price
Target price
Perf. (%)
€5.55
04.11.20
€7.90
04.11.21
25.95%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Splunk Inc.

Start price
Target price
Perf. (%)
€177.72
04.11.20
€189.00
04.11.21
-29.12%
10.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Expedia Inc.

Start price
Target price
Perf. (%)
€84.12
04.11.20
€159.00
04.11.21
82.48%
05.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
buy
Nidec Corp.

Start price
Target price
Perf. (%)
€90.84
04.11.20
€100.00
4.10%
09.11.20

Future proof or reliable business model
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.40
04.11.20
-
-9.38%
07.11.20

Could be very worthwhile Investment >20% year
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
American International Group Inc.

Start price
Target price
Perf. (%)
€27.87
04.11.20
-
04.11.21
20.65%
07.01.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Paychex Inc.

Start price
Target price
Perf. (%)
€73.88
04.11.20
-
04.11.21
1.96%
11.01.21

High dividend yield expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Qualcomm Inc.

Start price
Target price
Perf. (%)
€110.00
04.11.20
-
04.11.21
9.53%
24.11.20

buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€19.21
04.11.20
€25.00
04.11.21
78.65%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€31.30
04.11.20
€40.00
04.11.21
10.86%
05.11.20

Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.46
03.11.20
€3.50
04.11.21
-4.88%
05.11.21

Could be worthwhile Investment >10% per year
buy
SAP SE

Start price
Target price
Perf. (%)
€94.16
03.11.20
€110.00
04.11.21
7.80%
11.11.20

Could be worthwhile Investment >10% per year
Some uniques
Medium risks for its business
Well known brand
DuPont de Nemours Inc.

Start price
Target price
Perf. (%)
€50.84
03.11.20
€25.00
04.11.21
2.68%
10.11.20

buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group